project id: TCGA-SKCM; case submitter id: TCGA-BF-A1PX; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.7; concentration: 0.16; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.2; rna integrity number: 7.4; age at index: 56; days to birth: -20626; days to death: 282; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1954; year of death: 2010; age at diagnosis: 20626; ajcc pathologic m: M0; ajcc pathologic n: N2a; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T4b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C44.9; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Skin, NOS; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 122; initial weight: 260.0; sample id: ee2f9863-0dae-4830-a780-e7745414bc3d; sample submitter id: TCGA-BF-A1PX-01A; portion id: 2e5b022f-9f74-431f-b4aa-a33131b56508; portion submitter id: TCGA-BF-A1PX-01A-12; slide id: c395357c-ba9a-48a0-a33b-3cfaba1d03cb; slide submitter id: TCGA-BF-A1PX-01A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 10.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 10.0; percent tumor cells: 70.0; percent tumor nuclei: 85.0; section location: TOP;